BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16316067)

  • 1. Impact of Blow/Fill/Seal process variables in determining rate of vial contamination by air dispersed microorganisms.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2005; 59(5):320-31. PubMed ID: 16316067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges to a blow/fill/seal process with airborne microorganisms having different resistances to dry heat.
    Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2006; 60(5):323-30. PubMed ID: 17089701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airborne microbial challenges of Blow/Fill/Seal equipment: a case study.
    Bradley A; Probert SP; Sinclair CS; Tallentire A
    J Parenter Sci Technol; 1991; 45(4):187-92. PubMed ID: 1770413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of blow/fill/seal equipment under controlled airborne microbial challenges.
    Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 1995; 49(6):294-9. PubMed ID: 8581461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Blow/Fill/Seal extrusion through processing polymer contaminated with bacterial spores and endotoxin.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2004; 58(3):147-58. PubMed ID: 15233254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airborne contamination during blow-fill-seal pharmaceutical production.
    Whyte W; Matheis W; Dean-Netcher M; Edwards A
    PDA J Pharm Sci Technol; 1998; 52(3):89-99. PubMed ID: 9691671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S; Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2009; 63(1):71-80. PubMed ID: 19455943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
    Jones DJ; Topping P; Sharp J
    PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) Parenterals.
    Buecheler JW; Luemkemann J; Gieseler H; Mohl S; Streubel A
    PDA J Pharm Sci Technol; 2019; 73(2):111-120. PubMed ID: 30361287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity.
    Ovadia R; Streubel A; Webb-Vargas Y; Ulland L; Luemkemann J; Rauch K; Eder J; Lam P; Tegoulia V; Maa YF
    PDA J Pharm Sci Technol; 2019; 73(1):2-15. PubMed ID: 29954924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System.
    Oni Y; Song X; Schrader M; Kulshrestha A; Franck J; Asselta R; Flores-Crespo C; Mantri RV
    PDA J Pharm Sci Technol; 2019; 73(6):572-587. PubMed ID: 31101708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous microbiological air monitoring for aseptic filling lines.
    Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F
    PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the effect of sub(lethal) heat treatment of Bacillus subtilis spores on germination rate and outgrowth to exponentially growing vegetative cells.
    Smelt JP; Bos AP; Kort R; Brul S
    Int J Food Microbiol; 2008 Nov; 128(1):34-40. PubMed ID: 18926580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling vials aseptically while monitoring for bacterial contamination.
    Dirksen JW; Larsen RV
    Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous microbiological air monitoring for aseptic filling lines.
    Ginsbury K
    PDA J Pharm Sci Technol; 2007; 61(4):225. PubMed ID: 17933205
    [No Abstract]   [Full Text] [Related]  

  • 16. Loading and unloading of freeze-dryers: airborne contamination risks for aseptically manufactured sterile drug products.
    Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2007; 61(1):44-50. PubMed ID: 17390703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-Drying Process Development and Scale-Up: Scale-Up of Edge Vial Versus Center Vial Heat Transfer Coefficients, K
    Pikal MJ; Bogner R; Mudhivarthi V; Sharma P; Sane P
    J Pharm Sci; 2016 Nov; 105(11):3333-3343. PubMed ID: 27666376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmaceutical Capping Process-Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal Force.
    Mathaes R; Mahler HC; Vorgrimler L; Steinberg H; Dreher S; Roggo Y; Nieto A; Brown H; Roehl H; Adler M; Luemkemann J; Huwyler J; Lam P; Stauch O; Mohl S; Streubel A
    PDA J Pharm Sci Technol; 2016; 70(3):218-29. PubMed ID: 26797973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part II. Case studies in environmental monitoring during aseptic filling, intervention assessments, and glove integrity testing in manufacturing isolators.
    Miller MJ; Walsh MR; Shrake JL; Dukes RE; Hill DB
    PDA J Pharm Sci Technol; 2009; 63(3):259-83. PubMed ID: 20069799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate Generation Mechanisms during Bulk Filling and Mitigation via New Glass Vial.
    Timmons CL; Liu CY; Merkle S
    PDA J Pharm Sci Technol; 2017; 71(5):379-392. PubMed ID: 28512178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.